Considerations of strategies to provide influenza vaccine year round-Reference-Cited by-同舟云学术

Considerations of strategies to provide influenza vaccine year round

Published:2015-11 Issue:47 Volume:33 Page:6493-6498
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Lambach Philipp,Alvarez Alba Maria Ropero,Hirve Siddhivinayak,Ortiz Justin R.,Hombach Joachim,Verweij Marcel,Hendriks Jan,Palkonyay Laszlo,Pfleiderer Michael

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference40 articles.

1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet,2012

2. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008;Zhou;Clin Infect Dis,2012

3. Estimates of deaths associated with seasonal influenza—United States, 1976–2007;Centers for Disease Control and Prevention;MMWR Morb Mortal Wkly Rep,2010

4. Influenza surveillance in 15 countries in Africa, 2006–2010;Radin;J Infect Dis,2012

5. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis;Nair;Lancet,2011

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study;BMC Medicine;2023-03-22

2. Potential health and economic impact of paediatric vaccination using next generation influenza vaccines in Kenya: a modelling study;2022-08-26

3. Pandemic-response adenoviral vector and RNA vaccine manufacturing;npj Vaccines;2022-03-02

4. Feasibility of age- and gestation-based routine universal influenza vaccines schedules for children aged 6 months − 2 years and pregnant women;Vaccine;2021-11

5. Pandemic-response adenoviral vector and RNA vaccine manufacturing;2021-09-02